MedPath

Flow Controlled Ventilation in Thoracic Surgery

Not Applicable
Completed
Conditions
Positive-Pressure Respiration, Intrinsic
Registration Number
NCT04534933
Lead Sponsor
Medical University Innsbruck
Brief Summary

This trial investigates effects of individualized (by compliance guided pressure settings) flow-controlled ventilation compared to best clinical practice pressure-controlled ventilation in thoracic surgery requiring one lung ventilation.

Detailed Description

Flow-controlled ventilation (FCV) is a novel ventilation method with promising first results in porcine studies as well as clinical cross-over trials. A more efficient and maybe lung protective ventilation strategy would be crucial in the challenging situation of one lung ventilation during thoracic surgery, when the whole gas exchange has to be provided by just one half of the lungs.

Thus, individualized FCV, based on compliance guided pressure settings, will be compared to standard of pressure-controlled ventilation in thoracic surgery requiring one lung ventilation in a randomized controlled trial. Based on previous preclinical trials an improvement of oxygenation by 15% will be expected and in order to transfer the preclinical results to humans oxygenation assessed by paO2 / FiO2 ratio after 30 minutes of one lung ventilation is the main primary outcome parameter of this study. Furthermore, improved recruitment of lung tissue due to controlled expiratory flow in FCV will be anticipated without the need of recruitment maneuvers, which may cause deleterious effects on lung tissue. Accordingly any recruitment maneuvers will be omitted in the FCV group.

The investigators hypothesize that improved gas exchange in terms of improved oxygenation and reduced respiratory minute volume required for CO2-removal will be achieved with FCV compared to PCV. Secondary outcome parameters such as the incidence of postoperative pulmonary complications will be additionally assessed in order to plan future studies with clinically relevant outcome.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
46
Inclusion Criteria
  • Male and female subjects ≥ 18 years
  • Body weight ≥ 40 kg
  • Elective thoracic surgery requiring OLV
  • ASA I-III
  • Written informed consent
Exclusion Criteria
  • Emergency surgery
  • Female subjects known to be pregnant
  • Known participation in another interventional clinical trial
  • high pulmonary risk (ppo FEV1<20ml/kg in male or ppo FEV1<18ml/kg in female)
  • Empyema evacuation or signs of pulmonary infection
  • High grade CMP (EF<30%)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
paO2 / FiO2 ratio (Horowitz Index)after 30 minutes of one lung ventilation

Comparison of oxygenation assessed by arterial partial pressure of oxygen (paO2) / fraction of inspired oxygen (FiO2)

Secondary Outcome Measures
NameTimeMethod
respiratory complianceduring two lung ventilation in supine position after anesthesia induction (T1) and change to lateral position (T2), after 15 (T3), 30 (T4) and 60 minutes (T5) of one lung ventilation and after reinflation before tracheal extubation (T6)

Comparison of measured respiratory compliance

positive end-expiratory pressureduring two lung ventilation in supine position after anesthesia induction (T1) and change to lateral position (T2), after 15 (T3), 30 (T4) and 60 minutes (T5) of one lung ventilation and after reinflation before tracheal extubation (T6)

Comparison of set positive end-expiratory pressure

peak pressureduring two lung ventilation in supine position after anesthesia induction (T1) and change to lateral position (T2), after 15 (T3), 30 (T4) and 60 minutes (T5) of one lung ventilation and after reinflation before tracheal extubation (T6)

Comparison of set peak pressure

driving pressureduring two lung ventilation in supine position after anesthesia induction (T1) and change to lateral position (T2), after 15 (T3), 30 (T4) and 60 minutes (T5) of one lung ventilation and after reinflation before tracheal extubation (T6)

Comparison of resulting driving pressure

applied mechanical powerduring two lung ventilation in supine position after anesthesia induction (T1) and change to lateral position (T2), after 15 (T3), 30 (T4) and 60 minutes (T5) of one lung ventilation and after reinflation before tracheal extubation (T6)

Comparison of calculated applied mechanical power from the ventilator

respiratory resistanceduring two lung ventilation in supine position after anesthesia induction (T1) and change to lateral position (T2), after 15 (T3), 30 (T4) and 60 minutes (T5) of one lung ventilation and after reinflation before tracheal extubation (T6)

Comparison of measured respiratory resistance

mean arterial pressureduring two lung ventilation in supine position after anesthesia induction (T1) and change to lateral position (T2), after 15 (T3), 30 (T4) and 60 minutes (T5) of one lung ventilation and after reinflation before tracheal extubation (T6)

Comparison of measured mean arterial pressure

length of PACU stayTime from PACU admission to transfer to a general ward in hours

Duration of the patient at the post-anesthesia care unit (PACU)

central venous pressureduring two lung ventilation in supine position after anesthesia induction (T1) and change to lateral position (T2), after 15 (T3), 30 (T4) and 60 minutes (T5) of one lung ventilation and after reinflation before tracheal extubation (T6)

Comparison of measured central venous pressure

Concentration of plamatic cytokine levelspreoperative before induction of general anesthesia and postoperative at PACU admission and 1 hour thereafter

Plasmatic cytokine level of IL-6, IL-8, IL-10 and TNF-alpha will be assessed pre- (before induction of general anesthesia) and postoperative (ad PACU admission and 60 minutes therafter).

length of hospital staydays from surgery to hospital discharge

Comparison of length of hospital stay after thoracic surgery

postoperative pulmonary complications (PPC)until hospital discharge or day 30 of hospital stay

PPC will be assessd daily until hospital discharge or day 30 of hospital stay from the medical records during the follow-up period. The European Perioperative Clinical Outcome (EPCO) definition will be used to assess the occurrence of PPC.

decarboxylation (paCO2)during two lung ventilation in supine position after anesthesia induction (T1) and change to lateral position (T2), after 15 (T3), 30 (T4) and 60 minutes (T5) of one lung ventilation and after reinflation before tracheal extubation (T6)

Required respiratory minute volume to achieve a taregeted paCO2 of 35-45 mmHg during two lung ventilation and 40-60 mmHg during one lung ventilation

venous admixture (Qs / Qt)during two lung ventilation in supine position after anesthesia induction (T1) and change to lateral position (T2), after 15 (T3), 30 (T4) and 60 minutes (T5) of one lung ventilation and after reinflation before tracheal extubation (T6)

Comparison of calculated venous admixure from arterial and central venous blood gas analysis

respiratory minute volumeduring two lung ventilation in supine position after anesthesia induction (T1) and change to lateral position (T2), after 15 (T3), 30 (T4) and 60 minutes (T5) of one lung ventilation and after reinflation before tracheal extubation (T6)

Comparison of respiratory minute volume

heart rateduring two lung ventilation in supine position after anesthesia induction (T1) and change to lateral position (T2), after 15 (T3), 30 (T4) and 60 minutes (T5) of one lung ventilation and after reinflation before tracheal extubation (T6)

Comparison of measured heart rate

tidal volumeduring two lung ventilation in supine position after anesthesia induction (T1) and change to lateral position (T2), after 15 (T3), 30 (T4) and 60 minutes (T5) of one lung ventilation and after reinflation before tracheal extubation (T6)

Comparison of applied tidal volume

respiratory rateduring two lung ventilation in supine position after anesthesia induction (T1) and change to lateral position (T2), after 15 (T3), 30 (T4) and 60 minutes (T5) of one lung ventilation and after reinflation before tracheal extubation (T6)

Comparison of respiratory rate

Trial Locations

Locations (1)

Medical University Innsbruck

🇦🇹

Innsbruck, Tyrol, Austria

Medical University Innsbruck
🇦🇹Innsbruck, Tyrol, Austria

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.